Stock Track | Pharmaron Beijing Shares Plunge on Disappointing Q3 Results

Stock Track10-30

Shares of Pharmaron Beijing Co., Ltd. (HKG:3759, SHE:300759) plummeted by 5.06% on October 30, 2024, following the company's release of its third-quarter financial results. The pharmaceutical research and development services provider reported a 12.62% decline in net profit attributable to owners compared to the same period last year, missing market expectations.

According to the filing with the Hong Kong Stock Exchange, Pharmaron Beijing's net profit for the quarter ended September 30, 2024, stood at 308.4 million yuan (approximately $43.6 million), with earnings per share of 0.1744 yuan ($0.025), down 12.93% from a year earlier. While the company's revenue increased by 10.02% year-over-year to 3.21 billion yuan ($454.6 million), it failed to offset the impact of the profit decline.

The disappointing financial performance appears to have dampened investor sentiment, leading to a sell-off in the company's shares. Analysts cited concerns over Pharmaron Beijing's slowing growth and potential margin compression as potential factors contributing to the stock's decline.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1144401626?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-30 13:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1144401626","market":"hk","top_or_hot":-1,"title":"Stock Track | Pharmaron Beijing Shares Plunge on Disappointing Q3 Results","media":"Stock Track","content":"<p>Shares of Pharmaron Beijing Co., Ltd. (HKG:3759, SHE:300759) plummeted by 5.06% on October 30, 2024, following the company's release of its third-quarter financial results. The pharmaceutical research and development services provider reported a 12.62% decline in net profit attributable to owners compared to the same period last year, missing market expectations.</p>\n\n<p>According to the filing with the Hong Kong Stock Exchange, Pharmaron Beijing's net profit for the quarter ended September 30, 2024, stood at 308.4 million yuan (approximately $43.6 million), with earnings per share of 0.1744 yuan ($0.025), down 12.93% from a year earlier. While the company's revenue increased by 10.02% year-over-year to 3.21 billion yuan ($454.6 million), it failed to offset the impact of the profit decline.</p>\n\n<p>The disappointing financial performance appears to have dampened investor sentiment, leading to a sell-off in the company's shares. Analysts cited concerns over Pharmaron Beijing's slowing growth and potential margin compression as potential factors contributing to the stock's decline.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Pharmaron Beijing Shares Plunge on Disappointing Q3 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Pharmaron Beijing Shares Plunge on Disappointing Q3 Results\n</h2>\n\n<h4 class=\"meta\">\n\n2024-10-30 13:17 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Pharmaron Beijing Co., Ltd. (HKG:3759, SHE:300759) plummeted by 5.06% on October 30, 2024, following the company's release of its third-quarter financial results. The pharmaceutical research...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03759","symbol_name":"康龙化成","start_time":0,"source_url":"","article_id":"1144401626","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1144401626","pubTimestamp":1730265441,"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Pharmaron Beijing Co., Ltd.  plummeted by 5.06% on October 30, 2024, following the company's release of its third-quarter financial results. The pharmaceutical research and development services provider reported a 12.62% decline in net profit attributable to owners compared to the same period last year, missing market expectations.According to the filing with the Hong Kong Stock Exchange, Pharmaron Beijing's net profit for the quarter ended September 30, 2024, stood at 308.4 million yu","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03759":"康龙化成"},"translate_title":"股票赛道康龙化成北京股价因第三季度业绩令人失望而暴跌","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03759":1},"content_text":"Shares of Pharmaron Beijing Co., Ltd. (HKG:3759, SHE:300759) plummeted by 5.06% on October 30, 2024, following the company's release of its third-quarter financial results. The pharmaceutical research and development services provider reported a 12.62% decline in net profit attributable to owners compared to the same period last year, missing market expectations.\nAccording to the filing with the Hong Kong Stock Exchange, Pharmaron Beijing's net profit for the quarter ended September 30, 2024, stood at 308.4 million yuan (approximately $43.6 million), with earnings per share of 0.1744 yuan ($0.025), down 12.93% from a year earlier. While the company's revenue increased by 10.02% year-over-year to 3.21 billion yuan ($454.6 million), it failed to offset the impact of the profit decline.\nThe disappointing financial performance appears to have dampened investor sentiment, leading to a sell-off in the company's shares. Analysts cited concerns over Pharmaron Beijing's slowing growth and potential margin compression as potential factors contributing to the stock's decline.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1144401626"}